Skip to the page

Data / Medical devices / United States / Cairn Diagnostics

Cairn Diagnostics: FDA-registered device maker in Brentwood, TN, United States, 1 PMA approval

Cairn Diagnostics is registered with the FDA (registration 3010031043) in Brentwood, TN, United States. It lists 1 device type. The FDA files 1 PMA approval under its listings, the newest dated April 6, 2015. 1 recall event names it as the recalling firm. Registered through 2026. FDA data exported November 2, 2026.

SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.

FDA registration number
3010031043
FEI number
3009091796
Address
105 Westpark DR Ste 150, Brentwood, TN, United States, 37027
Owner or operator
Advanced Breath Diagnostics, LLC (10049228)
Roles
Manufacturer
First device listed
April 30, 2015
Registered through
2026
Brand names listed
13C-Spirulina, 13C-Spirulina GEBT, 13C-Spirulina Gastric Emptying Breath Test (GEBT), Gastric Emptying Breath Test (GEBT)

Devices it lists

DeviceProduct codeClassRoleSource
Gastric Emptying Breath TestPGE3Manufactureraccessdata.fda.gov

PMA approvals

Premarket approvals this establishment lists, with the supplements the FDA has decided since.

ApprovedPMA numberDeviceProduct codeSupplementsLatest decisionSource
April 6, 2015P110015GASTRIC EMPTYING BREATH TEST (GEBT)PGE10April 24, 2026accessdata.fda.gov

Recalls

Recall events where this establishment is the recalling firm, matched on its FEI.

InitiatedEventClassStatusProductReasonSource
January 8, 202187186Class IITerminated13C-Spirulina Gastric Emptying Breath Test (GEBT) - Product Usage: intended for use in the measurement of the rate of gastric emptying of solids and as an aid in the diagnosis of delayed gastric emptying (gastroparesis) Potential for false negative diagnosis of gastroparesis. Certain GEBT kits containing 13C-Spirulina elicit unusually high 13CO2-excretion ratesaccessdata.fda.gov

Updated April 24, 2026. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.